Clinical Trial Update: Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for osteosarcoma with pulmonary metastases investigating anti-angiogenic therapy combined with chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Pulmonary Metastases

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Osteosarcoma, Pulmonary Metastases | Phase 2 | Status: UNKNOWN